Filing Details
- Accession Number:
- 0001477932-17-000577
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2017-02-07 12:00:45
- Reporting Period:
- 2016-12-31
- Filing Date:
- 2017-02-07
- Accepted Time:
- 2017-02-07 12:00:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1498380 | Online Disruptive Technologies Inc. | ONDR | In Vitro & In Vivo Diagnostic Substances (2835) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1567275 | Ltd Borenstein Dr | 18 Reines St Tel Aviv L3 00000 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-07-31 | 600,000 | $0.10 | 6,400,000 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2013-10-10 | 1,000,000 | $0.10 | 6,400,000 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2013-12-03 | 4,700,000 | $0.10 | 6,400,000 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2014-02-14 | 4,417,000 | $0.10 | 12,617,000 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2014-03-11 | 500,000 | $0.10 | 12,617,000 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2014-09-08 | 1,000,000 | $0.10 | 12,617,000 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2014-11-19 | 300,000 | $0.10 | 12,617,000 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2015-04-01 | 200,000 | $0.10 | 12,881,500 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2015-04-02 | 64,500 | $0.10 | 12,881,500 | No | 5 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct |